KemPharm Inc

(NASDAQ:KMPH) Trade

Symbol has changed to a new ticker symbol

(KMPHD)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

KemPharm Inc is a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs that believe will be improved versions of widely prescribed, approved drugs. The company uses its Ligand Activated Therapy (LAT) platform technology to create prodrugs. Its LAT platform technology discovers and develops prodrugs that improve one or more of the attributes of approved drugs, such as susceptibility to abuse, bioavailability, and safety. KemPharm's two lead product candidates are KP415, ER d-threo-methylphenidate product candidate for the treatment of ADHD, and KP201/IR, APAP-free, single-entity, benzhydrocodone hydrochloride IR abuse-deterrent product candidate designed for the treatment of acute pain.

Contact Information

Website: www.kempharm.com
Email: info@kempharm.com
Main Phone: +1 321 939-3416
Address: 1180 Celebration Boulevard
Address 2: Suite 103
State: FL
City / Town: Celebration
Country: US
Postal Code: 34747

Issuer Information

Exchange: NSC
CEO: Travis C. Mickle
Employees: 22
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A